This site needs JavaScript to work properly. Please enable it to take advantage of the complete set of features!

Skip to main page content

Add to Collections

Your saved search

Name of saved search:

Search terms:

Test search terms

Would you like email updates of new search results?

Email: (change)

Frequency:

Which day?

Report format:

Send at most:

Send even when there aren't any new results

Optional text in email:

Your RSS Feed

Editorial

. 2024 Aug 8;144(6):592-593.

doi: 10.1182/blood.2024025130.

CARs vs bispecifics: the race is on!

Tanya Siddiqi¹

Affiliations

PMID: 39115828
DOI: 10.1182/blood.2024025130

Free article

Editorial

CARs vs bispecifics: the race is on!

Tanya Siddiqi. Blood. 2024.

Free article

. 2024 Aug 8;144(6):592-593.

doi: 10.1182/blood.2024025130.

Author

Tanya Siddiqi¹

Affiliation

¹ City of Hope Orange County.

PMID: 39115828
DOI: 10.1182/blood.2024025130

No abstract available

PubMed Disclaimer

Comment on

CAR T cells vs bispecific antibody as third- or later-line large B-cell lymphoma therapy: a meta-analysis.
Kim J, Cho J, Lee MH, Yoon SE, Kim WS, Kim SJ. Kim J, et al. Blood. 2024 Aug 8;144(6):629-638. doi: 10.1182/blood.2023023419. Blood. 2024. PMID: 38696731

References

Publication types

Actions
Actions

MeSH terms

Actions
Actions
Actions
Actions

Substances

Actions
Actions

LinkOut - more resources

Full Text Sources
- Elsevier Science
- Silverchair Information Systems

Save citation to file

Email citation

Add to Collections

Add to My Bibliography

Your saved search

Create a file for external citation management software

Your RSS Feed

CARs vs bispecifics: the race is on!

Affiliation

CARs vs bispecifics: the race is on!

Author

Affiliation

Comment on

References

Publication types

MeSH terms

Substances

LinkOut - more resources

Full Text Sources